CTOs on the Move


 
E COM is a Midlothian, VA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Paradigm Convergence

PCT Group is a mechanical engineering company specialized in lifting and handling equipment. The group provide bespoke solutions designing and manufacturing an extensive range of hoist, trolleys, winches, overhead cranes, jib cranes, gantry cranes, BOP handling systems, LNG pump handling systems, general handling accessories and special equipment, for most industrial and offshore installations, oil rigs, FPSOs, LNG plants, refineries, chemical plants and extreme environments, especially where hazardous areas (explosion atmospheres), low headroom, or radius are a requirement.

Guidant Group

Guidant Group is a Houston, TX-based company in the Business Services sector.

Advanced Photographics

Advanced Photographics is a Wilmington, MA-based company in the Business Services sector.

Decision Resources

Decision Resources, a Decision Resources Group company, is privately owned and offers a rich array of research publications, consulting and advisory services. For over three decades, Decision Resources has provided best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. With over 200 employees worldwide, analysts at Decision Resources provide the pharmaceutical, biotech and financial services industries with the analytics they need to compete and thrive in an increasingly competitive marketplace. With access to almost 10,000 thought leaders, specialists, HMO formulary directors and general practitioners, our highly-credentialed analysts are able to reconcile real-world practice with hard numbers from the industry's most respected data sources.  

Replay Therapeutics

Redefining gene therapy and genome editing with engineered high payload capacity HSV vectors. Developing best-in-class hypoimmunogenic iPSC therapeutic platform. Pioneering the age of genome writing.